Clinical Trial Update: Dose-Modulated Sonidegib Therapy for Periocular Basal Cell Carcinoma

View source ↗

Summary

A completed clinical trial evaluating dose-modulated sonidegib therapy for periocular basal cell carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Basal Cell Carcinoma
• Basal Cell Carcinoma of the Eyelid
• Basal Cell Carcinoma of the Head and Neck

Drugs mentioned

• Sonidegib (Sonidegib)

Snippet

Sponsor: Federico II University | Conditions: Basal Cell Cancer, Eyelid Tumor | Status: COMPLETED